Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Sept 2011

Lin Daniel W, FitzGerald Liesel M, Fu Rong, Kwon Erika M, Zheng Siqun Lilly, Kolb Suzanne, Wiklund Fredrik, Stattin Pär, Isaacs William B, Xu Jianfeng, Ostrander Elaine A, Feng Ziding, Grönberg Henrik, Stanford Janet L

Abstract excerpt

BACKGROUND: Prostate cancer is the second leading cause of cancer-related deaths in men, accounting for more than 30,000 deaths annually. The purpose of this study was to test whether variation in selected candidate genes in biological pathways of interest for prostate cancer progression could he...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Armadillo Domain Proteins
Share to Cell Adhesion Molecules

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryptochromes

Share to Endoribonucleases

Share to Interleukin-4

Share to Phosphoproteins

Share to Prostatic Neoplasms

Share to Receptors, Leptin

Source

Open in PubMed Open full text

Identifiers

PMID: 21846818
DOI: 10.1158/1055-9965.EPI-11-0236
PMCID: PMC3169727

Genes

ARVCF
CRY1
LEPR
RNASEL
IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21846818-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.PMID 21846818Read ↗

Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.Semantic proximity Read ↗

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.Semantic proximity Read ↗

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Genome-wide association study of prostate cancer mortality.Semantic proximity Read ↗

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Semantic proximity Read ↗

Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.Semantic proximity Read ↗

Genetic variation in RNASEL associated with prostate cancer risk and progression.Semantic proximity Read ↗

Replication of a genetic variant for prostate cancer-specific mortality.Semantic proximity Read ↗

Genome-wide association study of prostate cancer-specific survival.Semantic proximity Read ↗

Toll-like receptor signaling pathway variants and prostate cancer mortality.Semantic proximity Read ↗

Genetic variability in inflammation pathways and prostate cancer risk.Semantic proximity Read ↗

Common genetic and clinical risk factors: Association with fatal prostate cancer in the Cohort of Swedish MenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.